High prevalence of putative invasive pulmonary aspergillosis in critically ill COVID-19 patients
暂无分享,去创建一个
[1] Xavier Duval,et al. Clinical and virological data of the first cases of COVID-19 in Europe: a case series , 2020, The Lancet Infectious Diseases.
[2] Zunyou Wu,et al. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.
[3] J. Perfect,et al. Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[4] E. Andrinopoulou,et al. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. , 2018, The Lancet. Respiratory medicine.
[5] S. Bretagne,et al. Circulating Aspergillus fumigatus DNA Is Quantitatively Correlated to Galactomannan in Serum , 2017, Front. Microbiol..
[6] J. Rello,et al. A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients. , 2012, American journal of respiratory and critical care medicine.
[7] P. Jorens,et al. Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study , 2012, Intensive Care Medicine.